Literature DB >> 27379538

Gonadectomy prevents the increase in blood pressure and glomerular injury in angiotensin-converting enzyme 2 knockout diabetic male mice. Effects on renin-angiotensin system.

Sergi Clotet1, María José Soler, Marta Rebull, Javier Gimeno, Susan B Gurley, Julio Pascual, Marta Riera.   

Abstract

BACKGROUND: Angiotensin-converting enzyme 2 (ACE2) deletion worsens kidney injury, and its amplification ameliorates diabetic nephropathy. Male sex increases the incidence, prevalence, and progression of chronic kidney disease in our environment.
METHOD: Here, we studied the effect of ACE2 deficiency and gonadectomy (GDX) on diabetic nephropathy and its relationship with fibrosis, protein kinase B (Akt) activation, and the expression of several components of the renin-angiotensin system (RAS).Mice were injected with streptozotocin to induce diabetes and followed for 19 weeks. Physiological and renal parameters were studied in wild-type and ACE2 knockout (ACE2KO) male mice with and without GDX.
RESULTS: Diabetic ACE2KO showed increased blood pressure (BP), glomerular injury, and renal fibrosis compared with diabetic wild-type. Gonadectomized diabetic ACE2KO presented a decrease in BP. In the absence of ACE2, GDX attenuated albuminuria and renal lesions, such as mesangial matrix expansion and podocyte loss. Both, α-smooth muscle actin accumulation and collagen deposition were significantly decreased in renal cortex of gonadectomized diabetic ACE2KO but not diabetic wild-type mice. GDX also reduced circulating ACE activity in ACE2KO mice. Loss of ACE2 modified the effect of GDX on cortical gene expression of RAS in diabetic mice. Akt phosphorylation in renal cortex was increased by diabetes and loss of ACE2 and decreased by GDX in control and diabetic ACE2KO but not in wild-type mice.
CONCLUSIONS: Our results suggest that GDX may exert a protective effect within the kidney under pathological conditions of diabetes and ACE2 deficiency. This renoprotection may be ascribed to different mechanisms such as decrease in BP, modulation of RAS, and downregulation of Akt-related pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27379538     DOI: 10.1097/HJH.0000000000001015

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Authors:  Sergi Clotet; Maria Jose Soler; Marta Riera; Julio Pascual; Fei Fang; Joyce Zhou; Ihor Batruch; Stella K Vasiliou; Apostolos Dimitromanolakis; Clara Barrios; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

Review 2.  Intrarenal Angiotensin-Converting Enzyme: the Old and the New.

Authors:  Silas Culver; Caixia Li; Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2017-09-19       Impact factor: 5.369

3.  Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice.

Authors:  María José Soler; Marta Riera; Heleia Roca-Ho; Vanesa Palau; Javier Gimeno; Julio Pascual
Journal:  Lab Invest       Date:  2020-05-29       Impact factor: 5.662

Review 4.  Revisiting Experimental Models of Diabetic Nephropathy.

Authors:  Anna Giralt-López; Mireia Molina-Van den Bosch; Ander Vergara; Clara García-Carro; Daniel Seron; Conxita Jacobs-Cachá; Maria José Soler
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

Review 5.  Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies.

Authors:  Girish Pathangey; Priyal P Fadadu; Alexandra R Hospodar; Amr E Abbas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-25       Impact factor: 5.464

6.  Endothelial ADAM17 Expression in the Progression of Kidney Injury in an Obese Mouse Model of Pre-Diabetes.

Authors:  Vanesa Palau; Josué Jarrín; Sofia Villanueva; David Benito; Eva Márquez; Eva Rodríguez; María José Soler; Anna Oliveras; Javier Gimeno; Laia Sans; Marta Crespo; Julio Pascual; Clara Barrios; Marta Riera
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

7.  Redefining the Role of ADAM17 in Renal Proximal Tubular Cells and Its Implications in an Obese Mouse Model of Pre-Diabetes.

Authors:  Vanesa Palau; Sofia Villanueva; Josué Jarrín; David Benito; Eva Márquez; Eva Rodríguez; María José Soler; Anna Oliveras; Javier Gimeno; Laia Sans; Marta Crespo; Julio Pascual; Clara Barrios; Marta Riera
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

8.  Children With Short Stature Display Reduced ACE2 Expression in Peripheral Blood Mononuclear Cells.

Authors:  Federica Tonon; Gianluca Tornese; Fabiola Giudici; Francesca Nicolardi; Barbara Toffoli; Egidio Barbi; Bruno Fabris; Stella Bernardi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

9.  Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy.

Authors:  Vanesa Palau; Bramasta Nugraha; David Benito; Julio Pascual; Maximilian Y Emmert; Simon P Hoerstrup; Marta Riera; Maria José Soler
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

Review 10.  ACE2 mouse models: a toolbox for cardiovascular and pulmonary research.

Authors:  Hongpeng Jia; Xinping Yue; Eric Lazartigues
Journal:  Nat Commun       Date:  2020-10-14       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.